Lenvatinib-induced Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma

Lenvatinib is a multi-targeted tyrosine kinase inhibitor available for the treatment of unresectable hepatocellular carcinoma (HCC). We herein report an 84-year-old-man with interstitial pneumonia caused by lenvatinib. Four months after the start of lenvatinib administration for HCC, chest computed...

Descripción completa

Detalles Bibliográficos
Autores principales: Imakura, Takeshi, Sato, Seidai, Tomonari, Tetsu, Murakami, Kojin, Takahashi, Naoki, Naito, Nobuhito, Mima, Masato, Kagawa, Kozo, Koyama, Kazuya, Nishimura, Haruka, Kawano, Hiroshi, Nokihara, Hiroshi, Azuma, Masahiko, Takayama, Tetsuji, Nishioka, Yasuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107987/
https://www.ncbi.nlm.nih.gov/pubmed/34544944
http://dx.doi.org/10.2169/internalmedicine.7300-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107987/
https://www.ncbi.nlm.nih.gov/pubmed/34544944
http://dx.doi.org/10.2169/internalmedicine.7300-21

Ejemplares similares